Hikma Pharmaceuticals PLC (HIK) Stock Overview
London Stock Exchange · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products…
Source: Yahoo Finance
Sector & Industry
Hikma Pharmaceuticals PLC operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the London Stock Exchange exchange.
Hikma Pharmaceuticals PLC at a Glance
| Company | Hikma Pharmaceuticals PLC |
| Ticker | HIK |
| Exchange | London Stock Exchange |
| Currency | GBP |
| Price | £15.93 |
| Market cap | £3.30B |
| P/E ratio (trailing) | 12.25 |
| EPS (trailing) | £0.01 |
| 52-week high | £18.65 |
| 52-week low | £11.87 |
| Dividend yield | 3.98% |
| Ex-dividend date | 13 Aug 2026 |
| Beta | 0.66 |
| Return on equity (ROE) | 15.41% |
| Debt-to-equity | 77.11% |
| Average volume | 967,155 |
| Shares outstanding | 207.02M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 9,500 |
| Country | United Kingdom |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Frequently Asked Questions
- What is Hikma Pharmaceuticals PLC's current P/E ratio?
- Hikma Pharmaceuticals PLC (HIK) has a trailing P/E ratio of 12.25 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Hikma Pharmaceuticals PLC's market capitalisation?
- Hikma Pharmaceuticals PLC's market cap is £3.30B based on our latest snapshot. See how it ranks by market cap →
- What is HIK's 52-week range?
- Over the past 52 weeks, HIK has traded between £11.87 and £18.65. What does the 52-week range mean? →
- How volatile is Hikma Pharmaceuticals PLC compared to the market?
- Hikma Pharmaceuticals PLC has a beta of 0.66, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Hikma Pharmaceuticals PLC pay a dividend?
- Hikma Pharmaceuticals PLC's trailing annual dividend yield is 3.98%. Compare with other high-yield stocks →
- What exchange is HIK listed on?
- HIK is listed on the London Stock Exchange. Browse all London Stock Exchange-listed stocks →
- What sector is Hikma Pharmaceuticals PLC in?
- Hikma Pharmaceuticals PLC is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Plain-English guides to tracking the FTSE with low-cost funds.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Guides written for UK investors — ISAs, SIPPs and the London market.
Check Price →